Suche
Filter by content type
Filter by content year
Filter by category
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
März 8, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
August 9, 2021 - … have been allocated between BioNTech, Pfizer and Fosun Pharma based on marketing and distribution rights. … profit is based on COVID-19 vaccine sales in Pfizer’s and Fosun Pharma’s territories and represents a net figure. In … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech und Pfizer schließen erste Dosierungs-Kohorte der Phase-1/2-Studie mit COVID-19-Impfstoffkandidaten in Deutschland ab
April 29, 2020 - … in Europa sicherstellen. BioNTech arbeitet gemeinsam mit Fosun Pharma an der Entwicklung von BNT162 innerhalb Chinas, … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163
Dezember 21, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech Announces Plans for a Clinical Trial hub in Taiwan for mRNA-based Cancer Immunotherapies as Part of Asia-Pacific Expansion
Dezember 16, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients
Oktober 1, 2021 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Oktober 23, 2023 - … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, … pharmaceutical collaborators, including Duality Biologics, Fosun Pharma, Genentech, a member of the Roche Group, …
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACR
April 11, 2022 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma and Pfizer. For more information, please visit …
BioNTech und Pfizer geben Genehmigung des Paul-Ehrlich-Instituts für erste klinische Studie von COVID-19-Impfstoffkandidaten bekannt
April 22, 2020 - … sicherstellen. Zudem arbeitet BioNTech gemeinsam mit Fosun Pharma an der Entwicklung von BNT162 innerhalb Chinas, … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …
Pfizer und BioNTech impfen erste US-Studienteilnehmer im Rahmen des globalen Programms zur COVID-19-mRNA-Impfstoffentwicklung
Mai 5, 2020 - … (China ausgenommen, wo BioNTech eine Zusammenarbeit mit Fosun Pharma für die klinische Entwicklung sowie die … Genentech (ein Unternehmen der Roche Gruppe), Genevant, Fosun Pharma und Pfizer. Weitere Information finden Sie … zwischen BioNTech und Pfizer sowie BioNTech und Fosun Pharma zur Entwicklung eines potenziellen Impfstoffs …